Please use this identifier to cite or link to this item:
|Title:||Case control analysis of LRRK2 Gly2385Arg in Alzheimer's disease|
|Authors:||Tan, E.K. |
|Source:||Tan, E.K., Lee, J., Chen, C.P., Wong, M.C., Zhao, Y. (2009-03). Case control analysis of LRRK2 Gly2385Arg in Alzheimer's disease. Neurobiology of Aging 30 (3) : 501-502. ScholarBank@NUS Repository. https://doi.org/10.1016/j.neurobiolaging.2007.07.010|
|Abstract:||Alzheimer's disease (AD) pathology has been described in Parkinson's disease (PD) patients with leucine-rich repeat kinase-2 (LRRK2) mutations. A common LRRK2 Gly2385Arg variant has been widely shown to be associated with a twofold increased risk of PD in various Asian populations. In a case control study, the frequency of the heterozygous Gly2385Arg genotype was demonstrated in 4.3% of AD compared to 4.5% in controls (odds ratio = 0.94, 95% CI 0.37-2.42, p = 1.0). The Gly2385Arg variant does not appear to modulate the risk of AD in our population. © 2007 Elsevier Inc. All rights reserved.|
|Source Title:||Neurobiology of Aging|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Feb 15, 2018
WEB OF SCIENCETM
checked on Jan 31, 2018
checked on Feb 19, 2018
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.